Estrogen Patch vs. Pill: How Oral and Transdermal Hormone Therapy Compare
Estrogen pills and patches both treat menopause symptoms, but they reach the body differently. Here is how the routes compare on blood clot and stroke risk, everyday practicality, and who may lean toward each.
By Stone Health Editorial Team
Last updated

Key takeaways
- Estrogen for menopause can be taken by mouth (a pill) or through the skin (a patch, gel, or spray). Both treat hot flashes and night sweats.
- The main difference is how estrogen reaches the bloodstream. Pills pass through the liver first; patches, gels, and sprays largely bypass it.
- Large observational studies link oral estrogen to a higher risk of blood clots, while transdermal estrogen at standard doses has not shown the same increase. Stroke findings follow a similar pattern at lower doses.
- Route does not change the need for a progestogen. If you have a uterus, you need one with either a pill or a patch.
- Neither route is right for everyone. Your age, time since menopause, health history, and preferences all shape the choice, which is best made with a clinician.
The short answer
For many women, a pill and a patch work about equally well for menopause symptoms. Where they differ is safety for certain risks and day-to-day practicality. Because transdermal estrogen (absorbed through the skin) avoids a first pass through the liver, it has been associated in observational research with a lower risk of blood clots than oral estrogen. The Menopause Society notes that transdermal routes and lower doses may decrease the risk of venous thromboembolism and stroke. [1]
That makes transdermal estrogen a common choice for women with certain risk factors. But a pill can be a reasonable option for others, and some people simply prefer it. This guide explains what is known, what is still uncertain, and the practical tradeoffs.
If you are new to hormone therapy, start with our overview of hormone therapy for menopause: benefits, risks, and who it's for.
What "oral" and "transdermal" mean
Oral estrogen is a tablet you swallow, usually daily. In the U.S., common FDA-approved options include estradiol tablets and conjugated estrogens.
Transdermal estrogen is absorbed through the skin. FDA-approved forms include:
- Patches, usually changed once or twice a week depending on the brand. [2]
- Gels and emulsions, applied once a day to the arm or thigh. [3]
- Sprays, applied to the inner arm once a day. [3]
Systemic estrogen also comes as a vaginal ring designed to treat the whole body. That is different from low-dose vaginal estrogen (creams, tablets, inserts, and some rings), which mainly treats vaginal and urinary symptoms and is not the subject of this article. [4][5]
About the research
About the research: The studies described below looked at licensed prescription hormone products, mostly in the UK and France, as used in everyday practice. They were observational, which means they show associations, not proof of cause and effect. Compounded hormone preparations are not FDA-approved, and the FDA does not review them for safety, effectiveness, or quality before they are marketed. [6] These findings cannot be assumed to apply to compounded versions.
Why the route matters: the liver
When you swallow estrogen, it is absorbed from the gut and travels to the liver before reaching the rest of the body. This "first pass" exposes the liver to a higher concentration of estrogen, which can change how the liver makes certain proteins, including some involved in blood clotting. Estrogen absorbed through the skin enters the bloodstream directly and largely avoids this first-pass effect.
That biological difference is the leading explanation for why the two routes appear to carry different clot risks. It has not been tested head to head in a large randomized trial, so the evidence comes mainly from large observational studies.
Blood clots: the clearest difference
Venous thromboembolism (VTE) means a blood clot in a vein, such as deep vein thrombosis in the leg or a pulmonary embolism in the lungs. It is the risk where oral and transdermal estrogen differ most consistently.
- A large UK study (2019). Researchers compared about 80,000 women with VTE to about 390,000 women without it. Current use of oral hormone therapy was associated with higher odds of VTE (adjusted odds ratio 1.58) compared with no use. Transdermal preparations were not associated with a higher risk (adjusted odds ratio 0.93), a finding that was consistent across regimens. The authors described transdermal treatment as the safest type of hormone therapy with respect to VTE. [7]
- The type of estrogen pill may matter. In the same study, oral estradiol was associated with lower risk than conjugated equine estrogen, for both estrogen-only and combined therapy. [7]
- A French case-control study (ESTHER, 2007). Current users of oral estrogen had higher odds of VTE (odds ratio 4.2), while transdermal estrogen users did not (odds ratio 0.9). This study was much smaller, so its estimates are less precise. [8]
MedlinePlus, the National Library of Medicine's consumer resource, summarizes it this way: your risk for blood clots may be lower if you use estrogen skin patches instead of pills. [5]
Keep the absolute risk in perspective. VTE is uncommon in healthy women in their 50s, and the added risk is smaller in younger women who start therapy close to menopause. Personal factors such as a history of clots, obesity, smoking, or an inherited clotting disorder matter more, and they are a key reason a clinician may suggest a transdermal route.
Stroke
A UK study of more than 15,000 women with stroke and about 60,000 matched controls found that oral hormone therapy was associated with a modestly higher stroke rate (adjusted rate ratio 1.28). Low-dose estrogen patches (50 micrograms or less) were not associated with a higher rate. Higher-dose patches (more than 50 micrograms) were associated with a higher rate. [9]
The authors cautioned that residual confounding cannot be ruled out and that their results alone are not definitive proof that one route is safer. [9] MedlinePlus notes that using a patch instead of a pill decreases stroke risk, but that risk may still be higher than with no hormones at all. [5]
What about the progestogen?
If you have a uterus, estrogen on its own can thicken the uterine lining and raise the risk of endometrial cancer. A progestogen (progesterone or a progestin) protects against this. That is true whether your estrogen is a pill, a patch, a gel, or a spray. [4]
The type of progestogen may also matter for clot risk. In the ESTHER study, micronized progesterone and pregnane-derived progestins were not associated with higher VTE risk, while norpregnane-derived progestins were. [8] In the 2019 UK study, combined therapy with conjugated equine estrogen and medroxyprogesterone acetate had the highest risk of the oral options studied. [7] These are observational findings, and the progestogen choice is something to discuss with your clinician.
If you do not have a uterus (for example, after a hysterectomy), estrogen alone is usually used.
Effectiveness for symptoms
Both oral and transdermal estrogen are effective for hot flashes and night sweats, and both help prevent bone loss. The FDA notes that estrogen-only therapy comes as pills, skin patches, sprays, gels, and vaginal rings. [10] Choosing a route is usually about matching risks and preferences, not about one being much stronger for symptoms. For a broader comparison of hormonal and nonhormonal options, see our guide to hot flashes treatment.
Pill vs. patch vs. gel: a practical comparison
| Pill (oral) | Patch (transdermal) | Gel or spray (transdermal) | |
|---|---|---|---|
| How often | Usually daily | Once or twice a week, by brand [2] | Daily [3] |
| Passes through the liver first | Yes | Largely no | Largely no |
| Blood clot risk in observational studies | Higher than non-users [7][8] | Not clearly higher at standard doses [7][8] | Grouped with transdermal in most studies [7] |
| Common hassles | Remembering a daily dose | Skin redness or irritation; patch may loosen [2] | Needs time to dry; can transfer to others through skin contact [3] |
| Dose flexibility | Several tablet strengths | Several patch strengths | Adjustable by pumps or sprays |
Living with a patch
Patches are applied to clean, dry skin on the lower abdomen, below the waist, and some brands can go on the upper buttocks. They should not be placed on the breasts or on oily, irritated, or broken skin. It helps to rotate sites and wait at least a week before reusing the same spot. If a patch comes loose, press it back in place; if it will not stick, apply a new one and keep your usual change day. [2] Skin redness or irritation under the patch is the most common complaint.
Living with a gel or spray
Gels are usually applied in a thin layer to an arm or thigh, and sprays to the inner arm. Let the product dry, and do not apply it to the breasts or genital area. Because estrogen can transfer through skin contact, avoid letting others, especially children, touch the application site for at least an hour, and cover it with clothing. Gels and sprays can be flammable until dry. [3]
Who might lean toward one route
These are general patterns, not recommendations. A clinician will weigh your full history.
A clinician may favor transdermal estrogen if you:
- Have risk factors for blood clots, such as a higher body weight or a family history of clots
- Have risk factors for stroke
- Prefer not to take a daily pill
An oral option may suit you if you:
- Have had skin reactions to patches or prefer not to use skin products
- Find a once-daily tablet easier to remember
- Have no added clot or stroke risk factors and have discussed the tradeoffs with your clinician
Some people should not use systemic estrogen by any route, including those with a history of certain cancers, blood clots, stroke, or active liver disease. Timing matters too: for most healthy women who start before age 60 or within 10 years of menopause, the benefits of hormone therapy generally outweigh the risks. [1][11]
What changed with the FDA in 2026
In February 2026, the FDA approved labeling changes for menopausal hormone therapy that removed boxed-warning statements about cardiovascular disease, breast cancer, and probable dementia. [11] The boxed warning about endometrial cancer for systemic estrogen-alone products remains, and the FDA did not ask manufacturers to remove cardiovascular and breast cancer risks from the Warnings and Precautions section. [10] Product labels still describe the risk of blood clots, which is why route remains part of the conversation.
Questions to ask your clinician
- Given my health history, is a pill, patch, gel, or spray the better fit for me?
- Do I have any risk factors for blood clots or stroke that would change the route?
- Do I need a progestogen, and which type do you recommend?
- What dose will we start with, and how will we decide whether to adjust it?
- Is the product FDA-approved or compounded, and what does that mean for me?
- How often should we review whether I still need hormone therapy?
The bottom line
Estrogen pills and transdermal estrogen both treat menopause symptoms well. The most consistent difference is blood clot risk, which observational research links to oral estrogen more than to patches, gels, or sprays at standard doses. Route does not replace the need for a progestogen if you have a uterus, and it is only one part of a broader decision about whether hormone therapy fits your health and goals.
If you are weighing your options, Stone Health's clinicians can review your symptoms and history and talk through whether menopause hormone therapy may be appropriate for you, and which route makes sense. You can also browse our common questions or read more about perimenopause symptoms and menopause and sleep.
This article is for education only and is not medical advice. Talk with a licensed clinician about your individual situation.
Frequently asked questions
- Is the estrogen patch safer than the pill?
- For blood clots, large observational studies suggest transdermal estrogen (patch, gel, or spray) carries less risk than oral estrogen, and The Menopause Society says transdermal routes and lower doses may decrease the risk of blood clots and stroke. These studies show associations rather than proof, and the safest choice depends on your personal health history.
- Does the patch work as well as the pill for hot flashes?
- Both oral and transdermal estrogen are effective for hot flashes and night sweats. The choice between them is usually based on risk factors, side effects, and personal preference rather than strength.
- Do I still need progesterone if I use an estrogen patch?
- Yes, if you have a uterus. Estrogen alone can thicken the uterine lining and raise the risk of endometrial cancer, so a progestogen is needed whether estrogen comes as a pill, patch, gel, or spray.
- Is vaginal estrogen the same as a patch or pill?
- No. Low-dose vaginal estrogen mainly treats vaginal and urinary symptoms and has much less effect on the rest of the body. Patches, gels, sprays, pills, and some higher-dose vaginal rings are systemic therapy that treat the whole body.
- Can I switch from a pill to a patch?
- Many people can, but switching should be planned with your clinician, who can choose an appropriate dose and check whether you need a progestogen and how to time the change.
References
- The North American Menopause Society. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. doi:10.1097/GME.0000000000002028
- MedlinePlus (U.S. National Library of Medicine). Estradiol Transdermal Patch. Last revised May 15, 2025.
- MedlinePlus (U.S. National Library of Medicine). Estradiol Topical. Last revised May 15, 2026.
- U.S. Office on Women's Health. Menopause treatment. Updated October 19, 2026.
- MedlinePlus (U.S. National Library of Medicine). Deciding about hormone therapy. Reviewed March 17, 2026.
- U.S. Food and Drug Administration. Understanding the Risks of Compounded Drugs. Content current as of June 22, 2026.
- Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ. 2019;364:k4810. doi:10.1136/bmj.k4810
- Canonico M, Oger E, Plu-Bureau G, et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation. 2007;115(7):840-845. doi:10.1161/CIRCULATIONAHA.106.642280
- Renoux C, Dell'Aniello S, Garbe E, Suissa S. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ. 2010;340:c2519. doi:10.1136/bmj.c2519
- U.S. Food and Drug Administration. Hormone Replacement Therapies Can Help Women with Bothersome Menopausal Symptoms. Consumer Update; content current as of February 13, 2026.
- U.S. Food and Drug Administration. FDA Approves Labeling Changes to Menopausal Hormone Therapy Products. February 12, 2026.
This article is for educational purposes only and is not medical advice. It does not replace a consultation with a licensed clinician. Compounded medications are not FDA-approved. Talk to your clinician before starting, stopping, or changing any treatment. Read our editorial policy.
Related articles

Educational Guides
GLP-1 Weight Loss Plateau: Why It Happens and What to Do Next
Weight loss on a GLP-1 almost always slows down eventually. Here is why plateaus happen, how to tell if you have hit one, and what may help next.

Educational Guides
Menopause Insomnia: Why Sleep Changes and What Actually Helps
Trouble sleeping is one of the most common menopause symptoms. Here's why it happens, which treatments have the best evidence, and when poor sleep points to something else, like sleep apnea.

Educational Guides
What Happens When You Stop a GLP-1? Weight Regain, Side Effects, and How to Plan
GLP-1 medications work while you take them, and most people regain some weight after stopping. Here is what the research shows, what else changes, and how to plan with your clinician.

Educational Guides
Hot Flashes Treatment: What Works, From Hormone Therapy to Nonhormonal Options
Hot flashes can last for years, but there are effective treatments. Here is what the evidence says about hormone therapy, newer nonhormonal medicines, and nondrug options, and which popular remedies have not held up.